Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,724
datasets available to search
ShareScore release 0.9.0
Dataset results
1,724 results for “ESCALATOR”
Phase I Dose Escalation Study of Concomitant BIBF 1120 and BIBW 2992 in Patients With Advanced Solid Tumours.
ClinicalTrials.gov study NCT00998296. IPD Sharing: Not stated. Countries: 1. Publications: 1.
TBI Dose De-escalation for Fanconi Anemia
ClinicalTrials.gov study NCT00352976. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments
ClinicalTrials.gov study NCT03828292. IPD Sharing: NO. Countries: 1. Publications: 1.
Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies
ClinicalTrials.gov study NCT02457598. IPD Sharing: NO. Countries: 3. Publications: 6.
Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients
ClinicalTrials.gov study NCT03186677. IPD Sharing: NO. Countries: 1. Publications: 1.
A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT03871348. IPD Sharing: YES. Countries: 6. Publications: 1.
Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study
ClinicalTrials.gov study NCT02531295. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors.
ClinicalTrials.gov study NCT00816400. IPD Sharing: Not stated. Countries: 1. Publications: 1.
High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule
ClinicalTrials.gov study NCT01605097. IPD Sharing: NO. Countries: 1. Publications: 4.
Phase 1/2a Dose-Escalation Study of CRLX301 in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT02380677. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors
ClinicalTrials.gov study NCT03284723. IPD Sharing: NO. Countries: 6. Publications: 1.
An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 (Volasertib)in Combination With Oral BIBW 2992 (Afatinib) in Patients With Advanced Solid Tumours
ClinicalTrials.gov study NCT01206816. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00458237. IPD Sharing: NO. Countries: 1. Publications: 1.
A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Disease (GAUGUIN)
ClinicalTrials.gov study NCT00517530. IPD Sharing: Not stated. Countries: 2. Publications: 6.
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
ClinicalTrials.gov study NCT02302157. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)
ClinicalTrials.gov study NCT02616185. IPD Sharing: NO. Countries: 1. Publications: 1.
Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Clinical Activity of GSK2857916
ClinicalTrials.gov study NCT02064387. IPD Sharing: YES. Countries: 3. Publications: 4.
A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)
ClinicalTrials.gov study NCT02814175. IPD Sharing: YES. Countries: 14. Publications: 1.
Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer
ClinicalTrials.gov study NCT00142415. IPD Sharing: YES. Countries: 1. Publications: 2.
4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT03538743. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.